Palatin Technologies Depreciation & Amortization 2011-2026 | PTN

Annual Depreciation & Amortization Palatin Technologies

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
259 K	339 K	288 K	127 K	51.1 K	64.2 K	58.6 K	56.6 K	33.1 K	43.1 K	118 K	112 K	112 K	950 K	1.14 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.14 M	33.1 K	250 K

Quarterly Depreciation & Amortization Palatin Technologies

2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
14.4 K	14.4 K	-	-	71.8 K	80.8 K	-	-	-	87.4 K	-	-	-	59.6 K	129 K	-	-	12.6 K	40.2 K	-	-	13.4 K	23.9 K	13.4 K	-	18.3 K	36.5 K	18.3 K	-	14 K	27.9 K	14 K	-	14.6 K	28.9 K	14.6 K	-	7.63 K	15.3 K	7.63 K	-	10.7 K	22.2 K	10.7 K	-	27.6 K	55.2 K	27.6 K	-	27.2 K	56.6 K	27.2 K	-	27.5 K	54.8 K	27.5 K	-	255 K	501 K	255 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
501 K	7.63 K	55.5 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aptorum Group Limited APM	1.13 M	$ 0.81	1.28 %	$ 4.42 M	China
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
BioVie BIVI	229 K	$ 1.25	-	$ 1.85 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Atea Pharmaceuticals AVIR	416 K	$ 4.65	1.31 %	$ 392 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Axsome Therapeutics AXSM	503 K	$ 169.95	-2.75 %	$ 8.45 B	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
BeiGene, Ltd. BGNE	172 M	-	0.49 %	$ 251 B	Cayman-islands
Biogen BIIB	780 M	$ 195.13	-0.62 %	$ 28.6 B	USA
BioMarin Pharmaceutical BMRN	96.4 M	$ 62.62	-0.48 %	$ 11.9 B	USA
Bellicum Pharmaceuticals BLCM	11 K	-	-9.72 %	$ 5.89 M	USA
Baudax Bio BXRX	165 K	-	0.59 %	$ 63 K	USA
Aptose Biosciences APTO	32 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Aridis Pharmaceuticals ARDS	487 K	-	17.91 %	$ 11.1 M	USA
Amneal Pharmaceuticals AMRX	62.6 M	$ 14.66	1.66 %	$ 4.53 B	USA
Capricor Therapeutics CAPR	1.07 M	$ 27.91	0.14 %	$ 747 M	USA
CASI Pharmaceuticals CASI	468 K	$ 0.8	5.68 %	$ 109 M	USA